NES and breast carcinoma: In our experiments, the anti-breast cancer drug Chidamide acts on breast cancer cells to activate Nestin expression through LncRNA ENST869, and this “inappropriate expression” is just the result of self-protection of cancer cells against drugs, suggesting that Nestin may participate in the pharmacological action against Chidamide, which may be the key in breast cancer cell drug resistance.